LifeSpeak Inc.
TSX:LSPK.TO
0.37 (CAD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 12.422 | 12.401 | 12.949 | 12.898 | 13.164 | 13.396 | 13.755 | 12.766 | 12.139 | 8.71 | 6.838 | 5.921 | 5.585 | 4.922 | 3.177 | 2.519 | 2.412 | 1.976 |
Cost of Revenue
| 4.904 | 4.787 | 5.261 | 1.264 | 1.215 | 1.322 | 1.158 | 1.179 | 1.152 | 1.282 | 0.888 | 0.671 | 0.378 | 0.405 | 0.365 | 0.156 | 0.249 | 0.244 |
Gross Profit
| 7.518 | 7.614 | 7.688 | 11.634 | 11.949 | 12.074 | 12.597 | 11.587 | 10.987 | 7.428 | 5.95 | 5.25 | 5.207 | 4.517 | 2.812 | 2.363 | 2.163 | 1.732 |
Gross Profit Ratio
| 0.605 | 0.614 | 0.594 | 0.902 | 0.908 | 0.901 | 0.916 | 0.908 | 0.905 | 0.853 | 0.87 | 0.887 | 0.932 | 0.918 | 0.885 | 0.938 | 0.897 | 0.877 |
Reseach & Development Expenses
| 0 | 0 | 1.249 | 0 | 0 | 0 | 5.264 | 0 | 0 | 0 | 0.342 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 6.01 | 6.605 | 7.186 | 6.981 | 8.089 | 7.913 | 15.225 | 8.072 | 9.826 | 7.842 | 7.077 | 6.016 | 1.652 | 2.491 | 0.52 | 0.607 | 1.227 | 1.036 |
Selling & Marketing Expenses
| 2.944 | 2.64 | 2.747 | 2.476 | 2.947 | 2.7 | -4.04 | 2.662 | 3.555 | 3.469 | 2.905 | 2.525 | 1.935 | 1.689 | 1.064 | 0.872 | 0.952 | 0.797 |
SG&A
| 8.954 | 9.245 | 9.934 | 9.458 | 11.036 | 10.613 | 11.185 | 10.734 | 13.381 | 11.31 | 9.981 | 8.542 | 3.587 | 4.18 | 1.584 | 1.479 | 2.179 | 1.834 |
Other Expenses
| 2.806 | 0 | 0 | 0 | 0 | 4.016 | 3.715 | 4.421 | 4.29 | 2.566 | 1.013 | 0.028 | 0.014 | 0.014 | 0 | 0 | 0 | 0.014 |
Operating Expenses
| 8.954 | 9.245 | 9.934 | 13.383 | 15.152 | 14.629 | 14.9 | 15.155 | 17.671 | 13.876 | 10.994 | 8.57 | 3.601 | 4.194 | 1.6 | 1.493 | 2.193 | 1.848 |
Operating Income
| -1.436 | -1.63 | -2.246 | -1.775 | -3.241 | -2.586 | -2.319 | -3.628 | -6.701 | -7.168 | -6.619 | -3.32 | 1.606 | 0.322 | 1.218 | 0.868 | -0.032 | -0.115 |
Operating Income Ratio
| -0.116 | -0.131 | -0.173 | -0.138 | -0.246 | -0.193 | -0.169 | -0.284 | -0.552 | -0.823 | -0.968 | -0.561 | 0.288 | 0.066 | 0.383 | 0.345 | -0.013 | -0.058 |
Total Other Income Expenses Net
| -1.588 | -0.688 | -17.518 | 1.628 | -1.856 | 1.337 | -22.761 | 1.818 | -0.292 | -10.297 | -2.561 | -16.484 | -0.766 | -0.227 | -0.103 | -0.997 | -0.218 | -0.285 |
Income Before Tax
| -3.024 | -2.318 | -19.764 | -2.674 | -7.528 | -1.249 | -25.08 | -1.81 | -6.993 | -17.465 | -7.764 | -20.076 | 0.508 | 0.09 | 1.084 | -0.192 | -0.315 | -0.48 |
Income Before Tax Ratio
| -0.243 | -0.187 | -1.526 | -0.207 | -0.572 | -0.093 | -1.823 | -0.142 | -0.576 | -2.005 | -1.135 | -3.39 | 0.091 | 0.018 | 0.341 | -0.076 | -0.131 | -0.243 |
Income Tax Expense
| -0.78 | -0.715 | -2.089 | -0.692 | -1.277 | -0.894 | -1.383 | -0.405 | -0.536 | -1.11 | 0.227 | 0.253 | 0.323 | 0.006 | 0.031 | 0.063 | 0.066 | 0.08 |
Net Income
| -2.243 | -1.604 | -17.675 | -1.982 | -6.251 | -0.354 | -23.697 | -1.406 | -6.457 | -16.354 | -6.846 | -20.076 | 0.508 | 0.09 | 1.084 | -0.192 | -0.315 | -0.48 |
Net Income Ratio
| -0.181 | -0.129 | -1.365 | -0.154 | -0.475 | -0.026 | -1.723 | -0.11 | -0.532 | -1.878 | -1.001 | -3.39 | 0.091 | 0.018 | 0.341 | -0.076 | -0.131 | -0.243 |
EPS
| -0.038 | -0.031 | -0.35 | -0.039 | -0.12 | -0.007 | -0.47 | -0.028 | -0.13 | -0.33 | -0.22 | -0.43 | 0.011 | 0.002 | 0.023 | -0.004 | -0.007 | -0.01 |
EPS Diluted
| -0.038 | -0.031 | -0.35 | -0.039 | -0.12 | -0.007 | -0.47 | -0.028 | -0.12 | -0.33 | -0.22 | -0.43 | 0.011 | 0.002 | 0.023 | -0.004 | -0.007 | -0.01 |
EBITDA
| 2.104 | 1.873 | 1.73 | 2.15 | 0.875 | 1.43 | 1.396 | 0.793 | -2.411 | -4.601 | -3.963 | -3.311 | 1.612 | 0.337 | 1.234 | 0.882 | -0.018 | -0.101 |
EBITDA Ratio
| 0.169 | 0.151 | 0.134 | 0.167 | 0.067 | 0.107 | 0.101 | 0.062 | -0.199 | -0.528 | -0.58 | -0.559 | 0.289 | 0.068 | 0.388 | 0.35 | -0.007 | -0.051 |